Improved patient understanding through insights derived from social-behavioral data. A global pharma company worked with in-house analysts and a range of external vendors to prepare for the market launch of their new hematology drug. Despite having a thorough launch-planning process, the team was not confident in their understanding of non-clinical factors which impact the patient journey and access to therapy. The company sought an analytics partner that could help them dissect social and behavioral determinants of health (SBDoH) data to better understand patient preferences and challenges, as they fine-tune targeting and messaging.

Join for free to read